Kairos Pharma (NYSEAMERICAN:KAPA) Earns Buy Rating from Analysts at HC Wainwright
HC Wainwright began coverage on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a report released on Thursday ...
Needham & Company LLC Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price reduced by Needham & Company LLC from $202.00 to $183.00 in a report published on Thursday,Benzinga reports. Needham & Company LLC ...